Stramer SL - Search Results

1

Investigational Testing for Zika Virus among U.S. Blood Donors.

Saá P, Proctor M, Foster G, Krysztof D, Winton C, Linnen JM, Gao K, Brodsky JP, Limberger RJ, Dodd RY, Stramer SL. Saá P, et al. Among authors: stramer sl. N Engl J Med. 2018 May 10;378(19):1778-1788. doi: 10.1056/NEJMoa1714977. N Engl J Med. 2018. PMID: 29742375 Free article.

2

Indeterminate results in blood donor testing: what you don't know can hurt you.

Dodd RY, Stramer SL. Dodd RY, et al. Among authors: stramer sl. Transfus Med Rev. 2000 Apr;14(2):151-60. doi: 10.1016/s0887-7963(00)80005-x. Transfus Med Rev. 2000. PMID: 10782499 Review. No abstract available.

3

Risk of hepatitis and retroviral infections among blood donors and introduction of nucleic acid testing (NAT).

Dodd RY, Stramer SL, Aberle-Grasse J, Notari E. Dodd RY, et al. Among authors: stramer sl. Dev Biol (Basel). 2000;102:19-27. Dev Biol (Basel). 2000. PMID: 10794087 Review.

4

Nucleic acid testing for transfusion-transmissible agents.

Stramer SL. Stramer SL. Curr Opin Hematol. 2000 Nov;7(6):387-91. doi: 10.1097/00062752-200011000-00011. Curr Opin Hematol. 2000. PMID: 11055512 Review.

5

Misclassification of HCV-viremic blood donors as indeterminate by RIBA 3.0 because of human superoxide dismutase reactivity.

Tobler LH, Stramer SL, Kleinman SH, Brodsky JP, Todd DS, Busch MP. Tobler LH, et al. Among authors: stramer sl. Transfusion. 2001 Dec;41(12):1625-6. doi: 10.1046/j.1537-2995.2001.41121625.x. Transfusion. 2001. PMID: 11778082 No abstract available.

6

US NAT yield: where are we after 2 years?

Stramer SL. Stramer SL. Transfus Med. 2002 Aug;12(4):243-53. doi: 10.1046/j.1365-3148.2002.00387.x. Transfus Med. 2002. PMID: 12220253 Review.

7

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population.

Dodd RY, Notari EP 4th, Stramer SL. Dodd RY, et al. Among authors: stramer sl. Transfusion. 2002 Aug;42(8):975-9. doi: 10.1046/j.1537-2995.2002.00174.x. Transfusion. 2002. PMID: 12385406

8

Viral marker rates among blood donors before and after the terrorist attacks on the United States on September 11, 2001.

Dodd RY, Orton SL, Notari EP 4th, Stramer SL. Dodd RY, et al. Among authors: stramer sl. Transfusion. 2002 Sep;42(9):1240-1. doi: 10.1046/j.1537-2995.2002.00231.x. Transfusion. 2002. PMID: 12430686 No abstract available.

9

Transmission of West Nile virus through blood transfusion in the United States in 2002.

Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, Stobierski MG, Signs K, Newman B, Kapoor H, Goodman JL, Chamberland ME; West Nile Virus Transmission Investigation Team. Pealer LN, et al. Among authors: stramer sl. N Engl J Med. 2003 Sep 25;349(13):1236-45. doi: 10.1056/NEJMoa030969. Epub 2003 Sep 18. N Engl J Med. 2003. PMID: 14500806 Free article.

10

Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening.

Tobler LH, Stramer SL, Lee SR, Masecar BL, Peterson JE, Davis EA, Andrews WE, Brodsky JP, Kleinman SH, Phelps BH, Busch MP. Tobler LH, et al. Among authors: stramer sl. Transfusion. 2003 Oct;43(10):1452-9. doi: 10.1046/j.1537-2995.2003.00521.x. Transfusion. 2003. PMID: 14507279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters